Takeda Pharmaceutical (TAK) Amortizatization of Intangibles (2018 - 2019)

Takeda Pharmaceutical (TAK) recorded quarterly Amortizatization of Intangibles of -$0.95 in Q3 2019, up 0.73% quarter-over-quarter from -$0.96 in Q2 2019, and down 342.56% on a YoY basis from $0.39 in Q3 2018.

Takeda Pharmaceutical (TAK) Amortizatization of Intangibles (2018 - 2019) Analysis & Trends

Takeda Pharmaceutical's Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at -$0.95 for Q3 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn -
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn -
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn -
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 1.30 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn -
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 242,000.00
10 Takeda Pharmaceutical 169,771.34 -6.60 Bn 4.39 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2019 -0.95
Sep 30, 2019 -0.95
Jun 30, 2019 -0.96
Jun 30, 2019 -0.96
Sep 30, 2018 -0.22
Sep 30, 2018 -0.22
Jun 30, 2018 -0.22
Jun 30, 2018 -0.22